Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondation Ophtalmologique Adolphe de Rothschild

About this trial

The patient presents to the ophthalmological emergencies and / or to the internal medicine department. NOIA clinical discovery Patient referred in radiology for brain and visual MRI. The two sequences added by the research (8 minutes) will be added to that of the treatment.

Eligibility criteria

Qualifiers

Patient over 18 years old

Patient with suspected NOIA, evoked after clinical examination by a specialized ophthalmologist

For which a brain and visual MRI is planned

Express consent to participate in the study

Disqualifiers

Contraindication to MRI (electrical device, metallic foreign body, claustrophobia)

Patient benefiting from a legal protection measure

Pregnant or breastfeeding woman

Trial design

Treatments tested in this trial

  • MRI

Treatment groups

No treatment groups listed